{"disease":{"id":"acute-ischemic-stroke","name":"Acute Ischemic Stroke","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":4,"pipeline_drug_count":0,"trial_count":21},"drugs":{"marketed":[{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Malignant Cerebral Edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Trevo Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Stentriever Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Stentriever Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Stentriever Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Stentriever Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device and a Trevo Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Stentriever Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"no-oac","indication_name":"Acute Ischemic Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"pf-07976016-formulation-a","indication_name":"Acute Ischemic Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07976016 Formulation A","generic_name":"pf-07976016-formulation-a","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Trevo Retriever","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Trevo Retriever 3D","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Trevo XP","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Trevo XP ProVue","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Catheter with Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-intervention","indication_name":"Acute Ischemic Stroke (Mechanical Thrombectomy) - Xtreem Micro Guidewire with Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter and Xtreem Micro Guidewire and Xtreem Micro Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non intervention","generic_name":"non-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":81,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05198492","title":"Short- and Long-term Health Effects of Air Pollution in Poland","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8300000,"lead_sponsor_name":"Medical University of Bialystok","has_results":false},{"nct_id":"NCT03258983","title":"Alpha-linolenic Acid and the Risk of ASCVD","phase":"","overall_status":"COMPLETED","enrollment_count":57053,"lead_sponsor_name":"Aalborg University Hospital","has_results":false},{"nct_id":"NCT06628817","title":"The Intensive Care Bundle with Mortality Reduction in Acute Ischemic Stroke Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":55000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05779215","title":"Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT06707987","title":"Post-registration Trial of the Non-immunogenic Staphylokinase in Acute Ischemic Stroke (FORPI Registry)","phase":"","overall_status":"COMPLETED","enrollment_count":23250,"lead_sponsor_name":"Supergene, LLC","has_results":false},{"nct_id":"NCT06613074","title":"Ali Pay Intelligent Navigation Applet-aided Pre-hospital Triage for Non-emergency Medical Service Patients With Acute Ischemic Stroke","phase":"NA","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03684629","title":"Computer Scan Based Analysing System on Improving Stroke Management Quality Evaluation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":16570,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05686070","title":"A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12327,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06904664","title":"An Application That Can Provide Early Warning of Temperature Health Risks and Give Protective Suggestions or Personalized Suggestions Based on Patients' Own Secondary Prevention Risk Factors Was Applied to Intervene, and the Intervention Effect of APP on Stroke Recurrence Risk Was Analyzed","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":10184,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT05864638","title":"Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT06125236","title":"Registration of Acute Ischemic Stroke With Large and Medium-sized Vascular Occlusion in Southwest China(LMVOS)","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"Zhengzhou Yuan","has_results":false},{"nct_id":"NCT06853535","title":"Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":5138,"lead_sponsor_name":"Sichuan Provincial People's Hospital","has_results":false},{"nct_id":"NCT07098143","title":"An Application Provides Personalized Suggestions Based on Secondary Prevention Risk Factors to Stroke Patients","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":5092,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT07097428","title":"An Application Provides Temperature-related Health Risk Warnings and Protective Recommendations on Stroke","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":5092,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT04956185","title":"Data Collection of Patients Admitted to the Stroke Unit","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT05757635","title":"A Research of Application of the New Model of Standardized Secondary Prevention of Stroke","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03734640","title":"Optimal Post Tpa-Iv Monitoring in Ischemic Stroke","phase":"NA","overall_status":"COMPLETED","enrollment_count":4922,"lead_sponsor_name":"Craig Anderson","has_results":false},{"nct_id":"NCT03479554","title":"China Antihypertensive Trial in Acute Ischemic Stroke II","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4810,"lead_sponsor_name":"Tulane University","has_results":false},{"nct_id":"NCT05644223","title":"Effectiveness and Safety of Edaravone Dexborneol in Acute Ischemic Stroke","phase":"","overall_status":"UNKNOWN","enrollment_count":4750,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT03281590","title":"Stroke and Cerebrovascular Diseases Registry","phase":"","overall_status":"COMPLETED","enrollment_count":4594,"lead_sponsor_name":"University of New Mexico","has_results":false},{"nct_id":"NCT07519889","title":"Observational Study to Assess the Safety of rhTNK-tPA (Mingfule®) vs. Rt-PA (Actilyse®) in Treating Acute Ischemic Stroke","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4500,"lead_sponsor_name":"CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT06861426","title":"Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4460,"lead_sponsor_name":"Ying Gao","has_results":false},{"nct_id":"NCT06320431","title":"ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT05424978","title":"Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an","phase":"","overall_status":"RECRUITING","enrollment_count":3600,"lead_sponsor_name":"Xi'an No.3 Hospital","has_results":false},{"nct_id":"NCT07316049","title":"Construction and Evaluation of an Intelligent Decision System for Reperfusion Therapy in Acute Ischemic Stroke","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04072705","title":"Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke","phase":"","overall_status":"COMPLETED","enrollment_count":2927,"lead_sponsor_name":"Gangnam Severance Hospital","has_results":false},{"nct_id":"NCT06965036","title":"Risk Factors and Outcomes of Ischemic Stroke Associated With Tandem or Isolated Cervical Artery Occlusion in Anterior and Posterior Circulation","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2880,"lead_sponsor_name":"Azienda Unità Sanitaria Locale della Romagna","has_results":false},{"nct_id":"NCT05845372","title":"Association of Prophylactic Use of Stress Ulcer Drugs and Clinical Outcomes in Patients With Acute Anterior Circulation Thrombectomy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2592,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03766581","title":"A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2366,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT06057467","title":"Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2351,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04980651","title":"Safety and Efficacy of Remote Ischemic Conditioning for Acute Ischemic Stroke","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2210,"lead_sponsor_name":"Yi Yang","has_results":false},{"nct_id":"NCT06058130","title":"Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2171,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04978701","title":"Dynamic Changes of the Human Microbiome Predict the Risk of Poor Prognosis in Patients With Acute Ischemic Stroke: a Multi-center Study","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06240468","title":"Dynamic Changes in Human Microbiome Predict the Risk of Adverse Outcomes in Patients With Acute Ischemic Stroke: a Multicenter Prospective Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT04640428","title":"COVID-19 Stroke Apical Lung Examination Study","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"King's College Hospital NHS Trust","has_results":false},{"nct_id":"NCT07045987","title":"Exploration and Establishment of an Early Warning System for Futile Reperfusion - A I S","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT04359589","title":"DSS's Role in Evaluating the Diagnosis and Treatment System of Ischemic Cardiovascular and Cerebrovascular Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":1900,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT03480698","title":"Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness","phase":"","overall_status":"COMPLETED","enrollment_count":1851,"lead_sponsor_name":"Ever Neuro Pharma GmbH","has_results":false},{"nct_id":"NCT07122934","title":"Posterior Circulation Clot Burden Score (Pc-CBS) Predicts Clinical Outcome After Acute Ischemic Stroke Related to Posterior Circulation Occlusions : An Externally Validated Radiological Score","phase":"","overall_status":"COMPLETED","enrollment_count":1828,"lead_sponsor_name":"Centre Hospitalier Universitaire Vaudois","has_results":false},{"nct_id":"NCT04304508","title":"Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1808,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT06194968","title":"Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study","phase":"","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"The First Affiliated Hospital of Zhengzhou University","has_results":false},{"nct_id":"NCT05745259","title":"Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1630,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT07318948","title":"BALANCE Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Bo Wu","has_results":false},{"nct_id":"NCT05700591","title":"rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1552,"lead_sponsor_name":"Tasly Biopharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT03481777","title":"Remote Ischemic Conditioning in Patients With Acute Stroke (RESIST)","phase":"NA","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Grethe Andersen","has_results":true},{"nct_id":"NCT06220981","title":"The Oslo Acute Reperfusion Stroke Study (OSCAR)","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT07269288","title":"The Correlation and Mechanistic Study of GGCX Gene With Prognosis in Acute Ischemic Stroke","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Peking University Aerospace Center Hospital","has_results":false},{"nct_id":"NCT06290076","title":"A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT04797013","title":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1430,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT05295173","title":"A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1412,"lead_sponsor_name":"Angde Biotech Pharmaceutical Co., Ltd.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}